The equities market continues to be incredibly volatile. Investors were optimistic following a robust rally in Jan.; all major U.S. indices are down since then.
In this article, we discuss one of my favorite dividend growth stocks, which makes up for a low yield by being a consistent source of outperforming total returns. The company has a stellar high-moat M

Danaher: Compounder Starts To Look Attractive

05:11am, Sunday, 05'th Mar 2023
Danaher has benefited from the Covid-19 period. The company has seen strong (earnings) growth, and it's positioned to maintain this.
We start with a discussion of diversification theories based on the findings of a scientific article called "The Dividend Puzzle". While inexperienced investors should stick to ETFs, there's a clear c
All three companies have shown consistent revenue and EPS growth.
Despite the sharp slide in biotech stocks during 2022, the industry is still poised for mega growth.  Pandemic preparedness needs better vaccines and disease detection methods.
When many investors think about clean water stocks, the first thing that comes to mind for many investors is utility stocks. And hey, in today's volatile market, the relative safety and security that
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Yahoo Finance Live anchor Julie Hyman discusses how Life Storage, Newmont, and Danaher stocks are moving following reports of M&A activity.
Life Sciences Company Danaher Corp. DHR, -0.31% is interested in taking over contract manufacturer Catalent Inc. CTLT, -1.04% and is willing to pay a significant premium for the company, Bloomberg rep
Medical equipment maker Danaher Corp has expressed interest in taking over contract drugmaker Catalent Inc , Bloomberg News reported on Saturday, citing people familiar with the matter.

Danaher: A Future-Focused Spinoff Value Play

06:26pm, Monday, 30'th Jan 2023
In September 2022, Danaher Corp. ( DHR , Financial) announced its intention to spin off its environmental and applied solutions segment into a separate publicly traded business in the fourth quarter o
Danaher's (DHR) Q4 results benefit from strong segmental performances and organic sales growth.
Danaher Corporation (NYSE:DHR ) Q4 2022 Results Conference Call January 24, 2023 8:00 AM ET Company Participants John Bedford - Vice President-Investor Relations Rainer Blair - President and Chief Exe
The medical company's fourth-quarter earnings beat expectations, but analysts say investors are paying attention to other elements of the report.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE